Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Other Accumulated Expenses (2019 - 2025)

Phibro Animal Health (PAHC) has 9 years of Other Accumulated Expenses data on record, last reported at $1.9 million in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 95.96% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, down 95.96%, while the annual FY2025 figure was $31.2 million, 2369.33% up from the prior year.
  • Other Accumulated Expenses reached $1.9 million in Q4 2025 per PAHC's latest filing, up from $1.7 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $46.8 million in Q4 2024 and bottomed at $1.2 million in Q2 2022.
  • Average Other Accumulated Expenses over 5 years is $14.9 million, with a median of $17.6 million recorded in 2021.
  • The widest YoY moves for Other Accumulated Expenses: up 2369.33% in 2025, down 95.96% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $18.4 million in 2021, then fell by 2.65% to $17.9 million in 2022, then increased by 16.7% to $20.9 million in 2023, then skyrocketed by 124.05% to $46.8 million in 2024, then crashed by 95.96% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1.9 million in Q4 2025, $1.7 million in Q3 2025, and $31.2 million in Q2 2025.